Researcher
Pauline Lempens
Affiliations
- Mycobacteriology (Research unit)
Member
From12 Jan 2017 → 31 Dec 2021 - Mycobacteriology (Research unit)
Member
From12 Jan 2017 → 5 Dec 2020 - Mycobacteriology (Research unit)
Member
From14 Sep 2015 → 2 Sep 2016
Projects
1 - 2 of 2
- Novel High-Dose Tuberculosis Retreatment Regimens: How to overcome resistance without creating more?From1 Oct 2018 → Today
- First-line anti TB-drugs revisitedFrom12 Jan 2017 → 12 Apr 2023
Publications
1 - 10 of 10
- Borderline rpoB mutations transmit at the same rate as common rpoB mutations in a tuberculosis cohort in Bangladesh(2023)
Authors: Pauline Lempens, Armand Van Deun, Kya J M Aung, Mohammad A Hossain, Mahboobeh Behruznia, Tom Decroo, Leen Rigouts, Bouke de Jong, Conor J. Meehan
- First-line anti-tuberculosis drugs revisited(2023)
Authors: Pauline Lempens
Number of pages: 115 - Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century(2022)
Authors: Jean Claude Semuto Ngabonziza, Leen Rigouts, Tom Decroo, Eliane Kamanzi, Pauline Lempens, Aniceth Rucogoza, Yves Mucyo Habimana, Lies Laenen, Esdras Belamo Niyigena, Cécile Uwizeye, et al.
- Multidrug-resistant patients receiving treatment in Niger who are infected with M. tuberculosis Cameroon family convert faster in smear and culture than those with M. tuberculosis Ghana family(2020)
Authors: Mebrat Ejo Kitata, Mahamadou Bassirou Souleymane, Pauline Lempens, Jeroen Dockx, Cécile Uwizeye, Pim De Rijk, Tom Decroo, Ermias Diro, Gabriela Torrea, Leen Rigouts, et al.
- Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: nationwide programmatic achievements(2020)
Authors: Alberto Piubello, Mahamadou Bassirou Souleymane, Souleymane Hassane-Harouna, Abdourahamane Yacouba, Pauline Lempens, Mourtala Mohamed Assao-Neino, Ibrahim Maman-Lawan, Sala Attaher, Boubacar Moustapha, Alphazazi Soumana, et al.
- Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen(2020)
Authors: Pauline Lempens, Tom Decroo, Kya J M Aung, Mohammad A Hossain, Leen Rigouts, Conor J. Meehan, Armand Van Deun, Bouke de Jong
Pages: 357-365 - Fluoroquinolone heteroresistance in Mycobacterium tuberculosis: detection by genotypic and phenotypic assays in experimentally mixed populations(2019)
Authors: Leen Rigouts, Paolo Miotto, M. Schats, Pauline Lempens, Andrea Maurizio Cabibbe, S. Galbiati, Lampasona, P. de Rijkl, Daniela M Cirillo, Bouke de Jong
- Bridging the TB data gap: in silico extraction of rifampicin-resistant tuberculosis diagnostic test results from whole genome sequence data(2019)
Authors: Kamela Charmaine Sy Ng, Jean Claude Semuto Ngabonziza, Pauline Lempens, Bouke de Jong, Frank Van Leth, Conor J. Meehan
Pages: e7564 - The relationship between transmission time and clustering methods in Mycobacterium tuberculosis epidemiology(2018)
Authors: Conor Meehan, Pieter Moris, Thomas Andreas Kohl, Jūlija Pečerska, Suriya Akter, Matthias Merker, Christian Utpatel, Patrick Beckert, Florian Gehre, Pauline Lempens, et al.
Pages: 410-416 - Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations(2018)
Authors: Pauline Lempens, Conor J. Meehan, Koen Vandelannoote, Kristina Fissette, Pim De Rijk, Armand Van Deun, Leen Rigouts, Bouke de Jong